Linked Life Data

15448478

Source:http://linkedlifedata.com/resource/pubmed/id/15448478

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8 Suppl
pubmed:dateCreated
2004-9-27
pubmed:abstractText
Major problems in the management of keratomycosis stem from the difficulty of its diagnosis and limited choice of antifungal agents. In the present paper we propose a new method of detecting (1,3)-beta-D-glucan, one of the major components of fungal cell wall, in tears from an animal model of keratomycosis. In addition, we investigated the efficacy of topical application of micafungin, a new antifungal agent that inhibits the activity of (1,3)-beta-D-glucan synthase in this animal model.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0277-3740
pubmed:author
pubmed:issnType
Print
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S36-41
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
Potential use of (1,3)-beta-D-glucan as target of diagnosis and treatment of keratomycosis.
pubmed:affiliation
Department of Ophthalmology, University of Tsukuba Institute of Clinical Medicine, Tennoudai 1-1-1, Tsukuba, Ibaraki 305-8565, Japan. sanken-tky@umin.ac.jp
pubmed:publicationType
Journal Article